RNTX Earnings

Quarterly EPS
$-0.25
Q1 2025
$-0.28
Q2 2025
$-0.21
Q3 2025
$-1.09
Q4 2025
$-0.19
Q1 2026
$-0.10
Q2 2026
Latest RevenueN/A
Latest Net Income-6375000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.100-6375000—+64.3%
Q1 2026-$0.190-5838000—+24.0%
Q4 2025-$1.090-31967000——
Q3 2025-$0.210-5581000——
Q2 2025-$0.280-6822000——
Q1 2025-$0.250-5501000——
MarketsMoversWatchlist
Rein Therapeutics (RNTX) — Earnings